|
US5011912A
(en)
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
|
CZ321497A3
(cs)
|
1995-04-11 |
1998-06-17 |
Merck And Co., Inc. |
Způsob vhodný pro produkci látek, jejichž základ tvoří dipeptid
|
|
JP2001514508A
(ja)
|
1997-03-05 |
2001-09-11 |
ユニバーシティー オブ ワシントン |
Ｃ型肝炎ウイルスの複製を選択的に抑制する薬剤を同定するための新規なスクリーニング法
|
|
JP2002513295A
(ja)
|
1997-07-08 |
2002-05-08 |
ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド |
１２３種類のヒト分泌タンパク質
|
|
WO1999011667A1
(en)
|
1997-08-29 |
1999-03-11 |
Innogenetics N.V. |
METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
|
|
US6413783B1
(en)
|
1997-09-18 |
2002-07-02 |
Meso Scale Technologies, Llc |
Assay sonication apparatus and methodology
|
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
JP2004520803A
(ja)
|
2000-04-21 |
2004-07-15 |
コリクサ コーポレイション |
尋常性挫瘡の治療および診断のための組成物および方法
|
|
WO2002062945A2
(en)
|
2000-10-25 |
2002-08-15 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes and proteins
|
|
EP1349934A2
(en)
|
2000-11-20 |
2003-10-08 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
|
US7528227B2
(en)
|
2004-03-23 |
2009-05-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Histone H2A peptide derivatives and uses thereof
|
|
US7163943B2
(en)
|
2001-09-21 |
2007-01-16 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
US7393642B2
(en)
|
2003-07-17 |
2008-07-01 |
Chicago Community Foundation |
Methods and primers for diagnosing idiopathic congenital central hypoventilation syndrome
|
|
EP1668143B1
(en)
|
2003-09-30 |
2013-03-20 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
EP1732598A4
(en)
|
2003-12-31 |
2009-08-26 |
Pharmexa Inc |
TRIGGERING CELLULAR IMMUNE RESPONSES TO THE HUMAN PAPILLOVIRUS USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
|
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
|
JP4878551B2
(ja)
|
2004-04-08 |
2012-02-15 |
貞和 相磯 |
運動ニューロン疾患治療薬
|
|
EP1794593A2
(en)
*
|
2004-09-21 |
2007-06-13 |
Matritech, Inc. |
Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
|
|
CA2596588C
(en)
|
2005-01-31 |
2017-06-27 |
University Of Iowa Research Foundation |
Nucleic acid silencing of huntington's disease gene
|
|
WO2006133194A2
(en)
|
2005-06-06 |
2006-12-14 |
Vgx Pharmaceuticals, Inc |
Methods for treating viral infection with oral or injectible drug solution
|
|
CA2629294A1
(en)
|
2005-11-11 |
2007-05-24 |
Aurogen Inc. |
Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin
|
|
WO2008035096A1
(en)
*
|
2006-09-20 |
2008-03-27 |
Queen's University Of Belfast |
Assay
|
|
WO2008097861A2
(en)
|
2007-02-02 |
2008-08-14 |
Braincells, Inc. |
MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS
|
|
US20090148866A1
(en)
*
|
2007-05-18 |
2009-06-11 |
Abbott Laboratories |
Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase
|
|
WO2008151833A2
(en)
|
2007-06-13 |
2008-12-18 |
Hochschule Mannheim |
Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds
|
|
US20090143418A1
(en)
|
2007-11-30 |
2009-06-04 |
The Regents Of The University Of Michigan |
Compositions and Methods for Preventing and Treating Hair Growth Cycle-Related Conditions
|
|
GB0809821D0
(en)
|
2008-05-30 |
2008-07-09 |
Univ Aberdeen |
Treatment and diagnosis of behavioural disorders
|
|
TW201034684A
(en)
|
2009-02-18 |
2010-10-01 |
Genentech Inc |
Method for inhibiting neurodegeneration
|
|
WO2010115033A2
(en)
|
2009-04-02 |
2010-10-07 |
Regents Of The University Of Minnesota |
Nucleotide repeat expansion-associated polypeptides and uses thereof
|
|
PT2419144T
(pt)
|
2009-04-17 |
2019-09-16 |
Univ Oxford Innovation Ltd |
Composição para a administração de material genético
|
|
WO2010132982A1
(en)
|
2009-05-18 |
2010-11-25 |
Ottawa Hospital Research Institute |
Treatment of muscle disease characterized by insulin resistance
|
|
WO2011028912A2
(en)
|
2009-09-03 |
2011-03-10 |
University Of Tennessee Research Foundation |
A biomarker for neurodegeneration in neurological disease
|
|
KR101133243B1
(ko)
|
2009-10-29 |
2012-04-06 |
국립암센터 |
암의 진단 및 치료를 위한 ｅＩＦ３ｍ의 용도
|
|
WO2011121109A1
(en)
|
2010-04-02 |
2011-10-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
|
|
TWI654203B
(zh)
*
|
2010-11-30 |
2019-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
具有鈣依存性的抗原結合能力之抗體
|
|
LT2714071T
(lt)
|
2011-05-24 |
2019-10-10 |
Biontech Rna Pharmaceuticals Gmbh |
Individualizuotos vakcinos nuo vėžio
|
|
WO2013030588A1
(en)
|
2011-08-31 |
2013-03-07 |
The University Of Manchester |
Method for diagnosing a neurodegenerative disease
|
|
CA2853412C
(en)
|
2011-10-28 |
2021-05-04 |
University Of Zurich |
Tdp-43 specific binding molecules
|
|
CA2865011C
(en)
|
2012-02-29 |
2021-06-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
|
KR101417272B1
(ko)
|
2012-05-15 |
2014-07-14 |
경상대학교산학협력단 |
메트포민 및/또는 타이모퀴논을 포함하는 임신중 알코올 노출에 의한 신경질환 치료 또는 예방용 약학적 조성물
|
|
US20140100282A1
(en)
|
2012-10-10 |
2014-04-10 |
Patrick S L Wong |
Intranasal administration of pharmaceutical agents for treatment of neurological diseases
|
|
RS59283B1
(sr)
|
2013-01-22 |
2019-10-31 |
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V |
Proteini sa dipeptidnim ponovkom kao terapeutsko ciljno mesto kod neurodegenerativnih bolesti sa ekspanzijom heksanukleotidnog ponovka
|
|
WO2014114303A1
(en)
|
2013-01-22 |
2014-07-31 |
Deutsches Zentrum Für Neurodegenerative Erkrankungen |
Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion
|
|
WO2014116865A1
(en)
|
2013-01-24 |
2014-07-31 |
Mayo Foundation For Medical Education And Research |
Methods and materials for detecting c9orf72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or c9orf72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis
|
|
US10295547B2
(en)
|
2013-03-14 |
2019-05-21 |
University Of Florida Research Foundation, Incorporated |
Use and treatment of di-amino acid repeat-containing proteins associated with ALS
|
|
WO2014144952A2
(en)
|
2013-03-15 |
2014-09-18 |
Peter Walter |
Modulators of the eif2alpha pathway
|
|
WO2014186746A1
(en)
|
2013-05-16 |
2014-11-20 |
University Of Florida Research Foundation, Inc. |
HAIRPIN mRNA ELEMENTS AND METHODS FOR THE REGULATION OF PROTEIN TRANSLATION
|
|
EP2837390A1
(en)
|
2013-08-15 |
2015-02-18 |
Universitäts-Kinderspital beider Basel |
Combined Pharmaceutical Preparation for Use in Treating Neuromuscular Disorders
|
|
CA2990161A1
(en)
*
|
2014-08-13 |
2016-02-18 |
The Scripps Research Institute |
Treatment of c9ftd/als by targeting rna expanded repeat sequences
|
|
JP6508996B2
(ja)
*
|
2015-03-24 |
2019-05-08 |
東ソー株式会社 |
β−ＡＮＰによる心不全の検出方法
|
|
WO2016168143A1
(en)
|
2015-04-14 |
2016-10-20 |
Bristol-Myers Squibb Company |
IMMUNOASSAY FOR SOLUBLE PROGRAMMED DEATH-1 (sPD-1) PROTEIN
|
|
WO2016191241A1
(en)
|
2015-05-27 |
2016-12-01 |
Mmc & Company Llc |
Dual target mitochondrial impinging pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
|
|
US10509045B2
(en)
|
2015-05-29 |
2019-12-17 |
University Of Florida Research Foundation, Incorporated |
Methods for diagnosing Huntington's disease
|
|
EP3356827B1
(en)
*
|
2015-10-02 |
2023-12-06 |
Julius-Maximilians-Universität Würzburg |
Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
|
|
US10940161B2
(en)
|
2016-04-04 |
2021-03-09 |
University Of Florida Research Foundation, Incorporated |
Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
|
|
WO2018035408A1
(en)
|
2016-08-18 |
2018-02-22 |
Ovid Therapeutics Inc. |
Methods of treating developmental disorders with biguanides
|
|
EP3612190A4
(en)
|
2017-04-17 |
2021-01-20 |
University of Florida Research Foundation, Incorporated |
REGULATION OF RAN TRANSLATION THROUGH PKR AND EIF2A-P WAYS
|
|
EP3688020A4
(en)
|
2017-09-25 |
2021-07-14 |
University of Florida Research Foundation, Incorporated |
IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS
|
|
AU2018342105B2
(en)
|
2017-09-26 |
2023-11-16 |
University Of Florida Research Foundation, Incorporated |
Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
|
|
US11988676B2
(en)
|
2017-11-16 |
2024-05-21 |
Brainbox Solutions, Inc. |
Protein biomarker indicators of neurological injury and/or disease and methods of use thereof
|
|
US20220202935A1
(en)
|
2019-05-02 |
2022-06-30 |
Deutsches Zentrum Für Neurodegenrative Erkrankungen E.V.(Dzne) |
Immunogen for Preventing or Treating Familial Frontotemporal Dementia (FTD) and/or Amyotrophic Lateral Sclerosis (ALS)
|
|
WO2021007110A1
(en)
|
2019-07-05 |
2021-01-14 |
University Of Florida Research Foundation, Incorporated |
Methods for treating ran protein-associated neurological diseases
|
|
AU2020348916B2
(en)
|
2019-09-20 |
2025-12-18 |
University Of Florida Research Foundation, Incorporated |
Detection of antibodies against RAN proteins from serum and tissue lysates
|
|
US20230218730A1
(en)
|
2019-09-23 |
2023-07-13 |
University Of Florida Research Foundation, Incorporated |
Vaccine therapy for ran protein diseases
|
|
WO2021072187A2
(en)
|
2019-10-10 |
2021-04-15 |
University Of Florida Research Foundation, Incorporated |
Ran proteins as biomarkers in cag/ctg expansion disorders
|
|
US20230304088A1
(en)
|
2020-05-15 |
2023-09-28 |
University Of Florida Research Foundation, Incorporated |
Compositions and methods of detection of pre-symptomatic als
|
|
US20250041247A1
(en)
|
2021-12-01 |
2025-02-06 |
University Of Florida Research Foundation, Incorporated |
Small molecule inhibitors of repeat associated non-aug (ran) translation and combination therapies
|
|
WO2023164686A2
(en)
|
2022-02-28 |
2023-08-31 |
University Of Florida Researchfoundation, Incorporated |
Ran proteins in sporadic amyotrophic lateral sclerosis
|